Home Cart Sign in  
Chemical Structure| 7085-55-4 Chemical Structure| 7085-55-4

Structure of Troxerutin
CAS No.: 7085-55-4

Chemical Structure| 7085-55-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Troxerutin, also known as vitamin P4, can inhibit platelet aggregation and the production of ROS. It is a flavonol isolated from Sophora japonica and used as a vasoprotective.

Synonyms: Trihydroxyethylrutin; Vitamin P4; Z 6000

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Troxerutin

CAS No. :7085-55-4
Formula : C33H42O19
M.W : 742.68
SMILES Code : O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(OCCO)C(OCCO)=C4)OC5=CC(OCCO)=CC(O)=C15
Synonyms :
Trihydroxyethylrutin; Vitamin P4; Z 6000
MDL No. :MFCD00893813
InChI Key :IYVFNTXFRYQLRP-VVSTWUKXSA-N
Pubchem ID :5486699

Safety of Troxerutin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HaCaT cells 20, 50, 200, 500, 1000 µM 2 hours To evaluate the anti-inflammatory and antioxidant effects of TRX on TE-stimulated HaCaT cells. Results showed that TRX significantly improved cell viability and reduced the levels of inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α) and oxidative stress markers (ROS, MDA). Front Immunol. 2024 May 8;15:1369849
RAW264.7 cells 5.2–674 µM 24 hours To evaluate the cytotoxicity and nitric oxide inhibition potential of Troxerutin in RAW264.7 cells. Results showed that TXR at 674 μM concentration had no significant cytotoxicity and significantly inhibited SNP-stimulated nitrite production. Front Cell Dev Biol. 2022 Mar 31;10:845457
Human mesenchymal stem cells (MSCs) 0-200 µM 24, 48, 72 hours To evaluate the effect of TRX on MSCs cell viability, results showed that TRX had no significant inhibitory effects on MSCs cell viability even at concentrations up to 200 µM Front Pharmacol. 2021 Aug 9;12:723145
Human mesenchymal stem cells (MSCs) 100 µM, 200 µM 7 days (ALP activity assay), 14 days (calcium nodule formation assay) To evaluate the effect of TRX on osteogenic differentiation of MSCs, results showed that TRX enhanced ALP activity and calcium nodule formation in a dose-dependent manner, and upregulated the expression of osteogenic marker genes (OSX, Runx2, OPN) Front Pharmacol. 2021 Aug 9;12:723145

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Femur fracture model Intramuscular injection 100 µM, 200 µM Administered every other day for 4-6 weeks To evaluate the effect of TRX on fracture healing, results showed that the gaps between the fracture sites almost disappeared in TRX treated groups, the thickness of newly formed callus was significantly increased, and TRX promoted new bone formation and accelerated fracture healing Front Pharmacol. 2021 Aug 9;12:723145
Rats DHT-induced polycystic ovary syndrome model Intraperitoneal injection 150 mg/kg or 300 mg/kg Once daily for 4 weeks To investigate the protective effect and mechanism of troxerutin in a DHT-induced rat model of PCOS. Results showed that 300 mg/kg troxerutin significantly decreased the body weight gain and improved the pathological changes of ovary induced by DHT. Meanwhile, the elevated GnRH, gonadotrophin and testosterone in the serum of PCOS rats were reduced with the treatment of troxerutin. J Ovarian Res. 2020 Sep 13;13(1):106
Wistar rats Cisplatin-induced kidney injury model Gastric gavage 150 mg/kg/day Once daily for 14 days Troxerutin alleviates cisplatin-induced kidney injury by regulating the PI3K/AKT pathway via enhancing MAP4 expression, attenuating cellular apoptosis, and alleviating oxidative stress and inflammatory response. Food Nutr Res. 2022 May 24;66
ICR mice Mouse paw swelling model Subcutaneous injection 45 mg/kg Single injection, observed for 24 hours To evaluate the inhibitory effect of TRX on TE-induced paw swelling and inflammatory responses in mice. Results showed that TRX significantly reduced paw swelling and erythema and decreased the levels of inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α). Front Immunol. 2024 May 8;15:1369849
Swiss mice 5-FU-induced intestinal mucositis Oral 50, 100, 150 mg/kg Once daily for 3 days Troxerutin (100 mg/kg) prevented the 5-FU-induced histopathological changes and decreased oxidative stress by decreasing the MDA levels and increasing GSH concentration. TRX attenuated inflammatory process by decreasing MPO activity, intestinal mastocytosis, and COX-2 expression. TRX also reversed the depletion of goblet cells. Pharmaceuticals (Basel). 2020 Jan 8;13(1):10
ICR mice High-fat diet-induced diabetic mouse model Oral 150 mg/kg/day Daily administration for 20 weeks Troxerutin effectively improved obesity and related metabolic parameters, and liver injuries in HFD-treated mouse. Furthermore, troxerutin significantly attenuated enhancement of hepatic gluconeogenesis in HFD-fed mouse. Moreover, troxerutin notably suppressed nuclear factor-κB (NF-κB) p65 transcriptional activation and release of inflammatory cytokines in HFD-treated mouse livers. Mechanismly, troxerutin dramatically decreased Nucleotide oligomerization domain (NOD) expression, as well as interaction between NOD1/2 with interacting protein-2 (RIP2), by abating oxidative stress-induced ER stress in HFD-treated mouse livers. Int J Mol Sci. 2016 Dec 25;18(1):31
Wistar rats Adjuvant-induced arthritis (AIA) model Oral 50, 100, and 200 mg/kg Once daily for 15 days To evaluate the anti-arthritic effects of Troxerutin in the AIA rat model. Results demonstrated that TXR significantly reduced arthritis scores, footpad thickness, and plasma nitrite levels in a dose-dependent manner, with 200 mg/kg dose bringing the arthritis score to basal levels. Front Cell Dev Biol. 2022 Mar 31;10:845457

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.35mL

0.27mL

0.13mL

6.73mL

1.35mL

0.67mL

13.46mL

2.69mL

1.35mL

References

 

Historical Records

Categories